Sclerotherapy With Picibanil (OK‐432) for Congenital Lymphatic Malformation in the Head and Neck

Hypothesis/Objectives Congenital lymphatic malformations of the head and neck (LMHN) present special challenges to the otolaryngologist—head and neck surgeon. Recently, a number of sclerotherapy trials have shown promising results. In this study, we present our experiences with picibanil (OK‐432) sclerotherapy for this lesion.

[1]  J. Kasperbauer,et al.  Pediatric Lymphangiomas of the Head and Neck , 2000, The Annals of otology, rhinology, and laryngology.

[2]  N. Bauman,et al.  Treatment of Lymphangiomas in Children: An Update of Picibanil (OK-432) Sclerotherapy , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[3]  E. Deguchi,et al.  OK-432 therapy for lymphangioma in children: why and how does it work? , 1996, Journal of pediatric surgery.

[4]  M. Sung,et al.  Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. , 1995, American journal of otolaryngology.

[5]  K. Sie,et al.  Lymphatic malformations of the head and neck. A proposal for staging. , 1995, Archives of otolaryngology--head & neck surgery.

[6]  E. Deguchi,et al.  OK-432 therapy in 64 patients with lymphangioma. , 1994, Journal of pediatric surgery.